Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis
- PMID: 22068658
- PMCID: PMC3226754
- DOI: 10.1158/1078-0432.CCR-11-1944
Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis
Abstract
Purpose: Problems in management of oral cancers or precancers include identification of patients at risk for metastasis, tumor recurrence, and second primary tumors or risk for progression of precancers (dysplasia) to cancer. Thus, the objective of this study was to clarify the role of genomic aberrations in oral cancer progression and metastasis.
Experimental design: The spectrum of copy number alterations in oral dysplasia and squamous cell carcinomas (SCC) was determined by array comparative genomic hybridization. Associations with clinical characteristics were studied and results confirmed in an independent cohort.
Results: The presence of one or more of the chromosomal aberrations +3q24-qter, -8pter-p23.1, +8q12-q24.2, and +20 distinguishes a major subgroup (70%-80% of lesions, termed 3q8pq20 subtype) from the remainder (20%-30% of lesions, non-3q8pq20). The 3q8pq20 subtype is associated with chromosomal instability and differential methylation in the most chromosomally unstable tumors. The two subtypes differ significantly in clinical outcome with risk for cervical (neck) lymph node metastasis almost exclusively associated with the 3q8pq20 subtype in two independent oral SCC cohorts.
Conclusions: Two subtypes of oral lesions indicative of at least two pathways for oral cancer development were distinguished that differ in chromosomal instability and risk for metastasis, suggesting that +3q,-8p, +8q, and +20 constitute a biomarker with clinical utility for identifying patients at risk for metastasis. Moreover, although increased numbers of genomic alterations can be harbingers of progression to cancer, dysplastic lesions lacking copy number changes cannot be considered benign as they are potential precursors to non-3q8pq20 locally invasive, yet not metastatic oral SCC.
Figures


Similar articles
-
Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.BMC Cancer. 2014 May 21;14:353. doi: 10.1186/1471-2407-14-353. BMC Cancer. 2014. PMID: 24886209 Free PMC article.
-
Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.J Pathol. 2006 Sep;210(1):67-74. doi: 10.1002/path.2015. J Pathol. 2006. PMID: 16767698
-
Genomic DNA copy number alterations from precursor oral lesions to oral squamous cell carcinoma.Oral Oncol. 2014 May;50(5):404-12. doi: 10.1016/j.oraloncology.2014.02.005. Epub 2014 Mar 7. Oral Oncol. 2014. PMID: 24613650 Review.
-
Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.Lung Cancer. 2009 Dec;66(3):372-8. doi: 10.1016/j.lungcan.2009.02.017. Epub 2009 Mar 25. Lung Cancer. 2009. PMID: 19324446
-
Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.Front Immunol. 2022 Jan 27;13:840923. doi: 10.3389/fimmu.2022.840923. eCollection 2022. Front Immunol. 2022. PMID: 35154165 Free PMC article. Review.
Cited by
-
Designing biomarker studies for head and neck cancer.Head Neck. 2014 Jul;36(7):1069-75. doi: 10.1002/hed.23444. Head Neck. 2014. PMID: 25072057 Free PMC article. Review.
-
MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.Br J Cancer. 2015 Mar 3;112(5):891-900. doi: 10.1038/bjc.2015.19. Epub 2015 Feb 10. Br J Cancer. 2015. PMID: 25668004 Free PMC article.
-
The genetic determinants of oral diseases in Africa: The gaps should be filled.Front Oral Health. 2022 Oct 11;3:1017276. doi: 10.3389/froh.2022.1017276. eCollection 2022. Front Oral Health. 2022. PMID: 36304994 Free PMC article. Review.
-
Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.Int J Cancer. 2016 Jan 1;138(1):98-109. doi: 10.1002/ijc.29691. Epub 2015 Aug 28. Int J Cancer. 2016. PMID: 26175310 Free PMC article.
-
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma.Biomark Res. 2021 Jun 5;9(1):42. doi: 10.1186/s40364-021-00292-x. Biomark Res. 2021. PMID: 34090518 Free PMC article.
References
-
- Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33–64, 1. - PubMed
-
- Silverman SJ. Epidemiology. D.C. Decker Inc; 1998.
-
- Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005;103:1843–9. - PubMed
-
- Schmidt BL, Dierks EJ, Homer L, Potter B. Tobacco smoking history and presentation of oral squamous cell carcinoma. J Oral Maxillofac Surg. 2004;62:1055–8. - PubMed
-
- Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31:744–54. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials